Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial

Overview of attention for article published in BMC Cancer, February 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 2,540 followers.

RT @radoncpapers: Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial. https…

RT @radoncpapers: Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial. https…

RT @radoncpapers: Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial. https…

Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial. https://t.co/QH8t2fxlgx h/t @NCBI #RadOnc #PubMed

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.